RBC Microcap Value Fund earns a High Process Pillar rating. The main contributor to the rating is its parent firm's impressive long-term risk-adjusted performance, as shown by the firm's average ...

Donated blood is comprised of various components with 55 percent plasma, 45 percent red blood cells, and one percent ... during each Basic Leader Course cycle, held at the NCOA.

Here’s all you need to know about their new actively managed Life Science & Technology Fund (RLST). The RBC Life Science & Technology Fund (RLST) invests in a broad range of U.S. companies ...

Royal Bank of Canada’s top executive said the country’s economic policy has veered off track, and it needs a more competitive ...

RBC Capital Markets launched a $1.76 billion leveraged loan to help fund the planned buyout of wealth-management software ...

A brief summary - strong Buy, Buy, strong sell, sell or neutral signals for the Rbc Life Science & Technology Fund D fund. Access detailed technical analysis through moving averages buy/sell ...

Fund Ticker Symbol Management Fee RBC Life Science and Technology Fund – ETF Series RLST 0.75 % RBC U.S. Mid-Cap Growth Equity Fund – ETF Series RUMG 0.75 % ...

The RBC U.S. Mid-Cap Growth Equity Fund and the RBC Life Science and Technology Fund, managed by RBC Global Asset Management Inc. ("RBC GAM Inc."), offer diversified access to U.S. markets and now ...

In a report released yesterday, Logan Reich from RBC Capital maintained a Buy rating on Life Time Group Holdings (LTH – Research Report), with a price target of $27.00. The company’s shares ...

The survey commissioned by RBC’s homebuying platform Houseful show ... While the Bank of Canada has embarked on an easing cycle that’s set to lower borrowing costs in the months to come ...

The RBC U.S. Mid-Cap Growth Equity Fund and the RBC Life Science and Technology Fund, managed by RBC Global Asset Management Inc. (“RBC GAM Inc.”), offer diversified access to ...

RBC Life Science and Technology Fund – ETF Series aims to provide investors with long-term capital growth by investing primarily in equity securities of U.S. companies whose businesses relate to life ...